(3-Fluoro-2-(trifluoromethyl)phenyl)boronic acid, 95.0%, 250mg

4-Bromo-2,5-difluoroaniline, 98.0%, 100g

(2,2-difluoroethyl)(propyl)amine hydrochloride, 95.0%, 250mg

Methyl 2-((tert-butoxycarbonyl)amino)pent-4-enoate, 98%, 500mg

Methyl 6-chloro-3-methylpyrazine-2-carboxylate, 97%, 250mg

1-Piperazin-1-yl-2-p-tolyloxy-ethanonehydrochloride, 98.0%, 10g

2-Chloro-N-o-tolyl-acetamide, 95.0%, 1g

(4R)-2-(4-Fluorophenyl)thiazolidine-4-carboxylic acid, 95.0%, 5g

ethyl 7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate, 97%, 1g

Condensatore di Abbe 1,25 NA con apertura per campo scuro e vetrino per contrasto di fase. Senza vetrino per campo scuro e senza vetrini per contrasto di fase

2-(Benzyloxy)pyridine-4-boronic acid, 95%, 1g

2,2,2-Trichloroethanol, 95.0%, 5g

N-Phenylnicotinamide, 95.0%, 5g